Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02030067
Title Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Rexahn Pharmaceuticals, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.